<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02609243</url>
  </required_header>
  <id_info>
    <org_study_id>DiNA-P</org_study_id>
    <nct_id>NCT02609243</nct_id>
  </id_info>
  <brief_title>Diabetes Nutrition Algorithm - Prediabetes</brief_title>
  <acronym>DiNA-P</acronym>
  <official_title>Diabetes Nutrition Algorithm - Prediabetes (Dietary Strategies in the Prevention of Diabetes Mellitus Type 2 in a High-risk Cohort)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>German Institute of Human Nutrition</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Diabetes Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>German Institute of Human Nutrition</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prediabetes, defined by either impaired fasting glucose and/or impaired glucose tolerance, is
      a known high-risk condition predisposing to future diabetes mellitus type 2. Strategies to
      prevent progression from prediabetes to diabetes have been widely studied, however, without
      striking long-term effects of any kind of intervention (pharmacological, behavioral...). The
      investigators therefore investigate certain nutritional approaches concerning nutrient
      content and favorable food components, targeting metabolic improvement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prediabetes, defined by either impaired fasting glucose and/or impaired glucose tolerance, is
      a known high-risk condition predisposing to future diabetes mellitus type 2. Strategies to
      prevent progression from prediabetes to diabetes have been widely studied, however, without
      striking long-term effects of any kind of intervention (pharmacological, behavioral...). The
      investigators therefore investigate certain nutritional approaches concerning nutrient
      content and favorable food components, targeting metabolic improvement.

      The main comparison will assess differences in metabolic outcome due to low-carb or low-fat
      dietary intervention in short- and long-term design.

      Additionally, the role of PUFA will be assessed during long-term intervention to achieve
      better maintenance of metabolic improvements from the first study phase.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in postprandial glycaemia (2h plasma glucose level of the 75 g oral glucose tolerance test (OGTT))</measure>
    <time_frame>3 weeks, 6 months, 1 year, 3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>change in hepatic fat content confirmed by proton magnetic resonance spectroscopy by 3 T MR imaging</measure>
    <time_frame>3 weeks, 6 months, 1 year, 3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in insulin sensitivity confirmed by 75 g oral glucose tolerance test (OGTT)</measure>
    <time_frame>3 weeks, 6 months, 1 year, 3 years</time_frame>
    <description>insulin resistance is calculated as follows:
Insulinogenic index (IGI) = (I30 - I0) / (G30 - G0) ISIest= 10000/²√ ((G0 x I0) x ((G0+G30+G60+G90+G120)/5) x ((I0+I30+I60+I90+I120)/5))</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in insulin secretion confirmed by 75 g oral glucose tolerance test (OGTT)</measure>
    <time_frame>3 weeks, 6 months, 1 year, 3 years</time_frame>
    <description>insulin resistance is calculated as follows:
Insulinogenic index (IGI) = (I30 - I0) / (G30 - G0) ISIest= 10000/²√ ((G0 x I0) x ((G0+G30+G60+G90+G120)/5) x ((I0+I30+I60+I90+I120)/5))</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in distribution of body fat confirmed by MR-Imaging by 3 T whole body imager</measure>
    <time_frame>3 weeks, 6 months, 1 year, 3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Prediabetes</condition>
  <condition>Diabetes Mellitus Type 2</condition>
  <condition>Obesity</condition>
  <condition>NAFLD</condition>
  <condition>Dyslipoproteinemia</condition>
  <arm_group>
    <arm_group_label>intensive consulting, conventional diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subjects receive 16 units of nutritional consulting, first 3 weeks of intervention phase are designed as a conventional hypocaloric low-fat diet referring to DGE guidelines (below 30 % fat), followed by 11 months of isocaloric-to-moderate-hypocaloric low-fat diet (below 30 kcal% fat ) - dietary intervention without supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional consulting, low-carb diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subjects receive 8 units of nutritional consulting, first 3 weeks of intervention phase are designed as a very-low calory ketogenic (low-carb) diet (&lt; 40 g CH / day), following 11 months are restricted to not more than 40 % energy intake by carbohydrates under isocaloric-to-moderate-hypocaloric conditions - dietary intervention without supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional consulting, conventional diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subjects receive 8 units of nutritional consulting, first 3 weeks of intervention phase are designed as a conventional hypocaloric low-fat diet referring to DGE guidelines (below 30 % fat), followed by 11 months of isocaloric-to-moderate-hypocaloric low-fat diet (below 30 kcal% fat) - dietary intervention without supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intensive consulting, low-carb diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subjects receive 16 units of nutritional consulting, first 3 weeks of intervention phase are designed as a very-low calory ketogenic (low-carb) diet (&lt; 40 g CH / day), following 11 months are restricted to not more than 40 % energy intake by carbohydrates under isocaloric-to-moderate-hypocaloric conditions - dietary intervention without supplement</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>dietary consulting</intervention_name>
    <description>dietary consulting implies specific dietary advice based on pre-interventional self-report regarding food intake; consulting focuses on nutrient content, calory intake, weight loss; with regard to randomisation consulting intensity and content varies</description>
    <arm_group_label>intensive consulting, conventional diet</arm_group_label>
    <arm_group_label>conventional consulting, low-carb diet</arm_group_label>
    <arm_group_label>conventional consulting, conventional diet</arm_group_label>
    <arm_group_label>intensive consulting, low-carb diet</arm_group_label>
    <other_name>dietary intervention without supplement</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  impaired fasting glucose (IFG) fasting blood glucose 100-126 mg/dl

        and/or

          -  impaired glucose tolerance (IGT) 75 g OGTT 120 minutes: 140-200 mg/dl

        Exclusion Criteria:

          -  current pregnancy or breastfeeding

          -  BMI &gt; 45 kg/m²

          -  Diabetes mellitus Typ 1 or 2

          -  serious disease e.g symptomatic coronary heart disease

          -  serious symptomatic malignant disease (weight loss &gt; 10% within the last 6 month)

          -  severe liver or kidney disease ( an increase in transaminases &gt; 3 times than the upper
             limit of the standardized range, GFR &lt; 50 ml/min/1,73m²)

          -  systemic infection (CRP &gt; 1 mg/dl)

          -  severe mental illness

          -  drug abuse

          -  treatment with steroids

          -  potentially incompliant subjects

          -  exclusion criteria for magnetic resonance tomography

          -  any kind of metal in or on the body: cardiac pacemakers prosthetic heart valves metal
             prosthesis magnetic implanted metallic parts contraceptive coil metal fragments/
             grenade shrapnel fixed braces acupuncture needles insulin pump intraport etc. Field
             strength &gt; 3 Tesla further tattoos, permanent make-up

          -  persons with limited thermosensory or heightened sensitivity to heating

          -  persons where cardiovascular disease cannot be ruled out by examination

          -  persons with heightened sensitivity to loud noise or diseases of the ear

          -  used closed whole body scanner: claustrophobia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas FH Pfeiffer, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>German Institute of Human Nutrition</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan Kabisch, Dr. med.</last_name>
    <phone>030 450 514</phone>
    <phone_ext>429</phone_ext>
    <email>stefan.kabisch@charite.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Margrit Kemper, Dr.</last_name>
    <phone>033200 88 2775</phone>
    <email>margrit.kemper@dife.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>German Institut for Human Nutrition; Department for Clinical Nutrition</name>
      <address>
        <city>Nuthetal</city>
        <state>Brandenburg</state>
        <zip>14458</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margrit Kemper, Dr. med.</last_name>
      <phone>033200 88 2775</phone>
      <email>margrit.kemper@dife.de</email>
    </contact>
    <contact_backup>
      <last_name>Silke Hornemann</last_name>
      <phone>033200 88 2779</phone>
      <email>silke.hornemann@dife.de</email>
    </contact_backup>
    <investigator>
      <last_name>Margrit Kemper, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silke Hornemann</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christiana Gerbracht, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>German Institute for Human Nutrition, Department for Clinical Nutrition</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Kabisch, Dr. med.</last_name>
      <phone>030 450 514</phone>
      <phone_ext>429</phone_ext>
      <email>stefan.kabisch@charite.de</email>
    </contact>
    <contact_backup>
      <last_name>Ulrike Kaiser, M.sc.</last_name>
      <phone>030 450 514</phone>
      <phone_ext>428</phone_ext>
      <email>ulrike.kaiser@charite.de</email>
    </contact_backup>
    <investigator>
      <last_name>Stefan Kabisch, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ulrike Kaiser, M.sc.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2015</study_first_submitted>
  <study_first_submitted_qc>November 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2015</study_first_posted>
  <last_update_submitted>November 21, 2016</last_update_submitted>
  <last_update_submitted_qc>November 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>German Institute of Human Nutrition</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Andreas F. H. Pfeiffer</investigator_full_name>
    <investigator_title>Director / Department for Clinical Nutrition</investigator_title>
  </responsible_party>
  <keyword>prediabetes</keyword>
  <keyword>diabetes mellitus type 2</keyword>
  <keyword>obesity</keyword>
  <keyword>NAFLD</keyword>
  <keyword>dyslipoproteinemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

